Catalyst

Slingshot members are tracking this event:

TG Therapeutics (TGTX) withdraws BLA and sNDA for chronic lymphocytic leukemia, pulls Ukoniq from sale

Source Link:
https://ir.tgtherapeutics.com/news-releases/news-release-details/tg-therapeutics-announces-voluntary-withdrawal-blasnda-u2-treat

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
TGTX
100%
SIGN ME UP
I want to vote! LOG ME IN
Now!
Slingshot Insights Explained
JOIN FOR FREE TODAY
Catalyst Date
Occurred on:
Apr 15, 2022
Related Projects Image

  • Don’t see a project related to the catalyst you care about?

Related Keywords Ukoniq, Leukemia, Ublituximab, Chronic Lymphocytic Leukemia
About Us
Media Center
Connect with Us
© 2024 Slingshot Insights. All rights reserved.